Infinx IPO preparations are moving forward, with the healthcare technology company appointing Kotak Mahindra Capital, Nomura and Avendus to manage a proposed $300 million share sale in India, people familiar with the development said. As of October 23, 2026, the KKR- and Norwest Venture Partners-backed business was targeting a listing in FY28.
Key Takeaways
- The proposed offering could combine newly issued shares with sales by existing shareholders.
- The banker appointments and listing target have not been publicly confirmed by Infinx.
- Infinx supplies technology and services that help US healthcare providers manage billing and payment collection.
Table of Contents
- Infinx IPO structure remains provisional
- Private backing has supported expansion
- Business centers on US healthcare administration
- Conclusion
Infinx IPO structure remains provisional
The planned $300 million offering could include both a fresh issue and an offer for sale, the people said. The split between those components has not been specified.
That distinction matters for how the proceeds would be distributed: a fresh issue raises money for the company, while an offer for sale provides proceeds to selling shareholders. The proposed headline size therefore should not be treated as the amount Infinx itself would receive.
Infinx, Kotak Mahindra Capital and Nomura had not responded to requests for comment by publication time. The FY28 timetable remains a target rather than a completed listing or a firm trading date.
| Item | Details |
|---|---|
| Founded | 2012 |
| Operating locations | Teams in the United States, India and the Philippines |
| Customer types | Hospitals, health systems and physician groups |
| May 2025 acquisition price | $96 million for i3 Verticals' healthcare revenue cycle management business, including associated proprietary technology |
Private backing has supported expansion
Infinx remained bootstrapped until Norwest Venture Partners provided its first institutional capital in 2021. KKR acquired a significant minority stake in 2024 through its Asian Fund IV, with Norwest also participating in that transaction.
The company has raised a total of $186 million to support expansion and acquisitions. That historical funding figure is separate from the proposed IPO size.
Infinx's May 2025 acquisition announcement confirmed its purchase of i3 Verticals' healthcare revenue cycle management business. The company said the deal expanded its reach into academic medical centers and other large provider groups.
Business centers on US healthcare administration
Infinx combines AI-powered technology with services covering patient access, insurance verification, prior authorization, medical coding, billing and collections.
Its business focuses on the administrative and financial processes behind healthcare delivery, helping providers manage reimbursement and payment recovery rather than delivering clinical care.
Conclusion
The Infinx IPO remains a proposed transaction. Formal confirmation of the offering structure and listing timetable would clarify how much capital the company intends to raise and how much existing shareholders plan to sell.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
